France· FR:65554855
BUDESONIDE ARROW 1 mg/2 ml, suspension pour inhalation par nébuliseur en récipient unidose
A medicinal product containing budésonide, registered in France by ARROW GENERIQUES, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BUDÉSONIDE
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093626326020 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 2 mlEUR 24.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Budésonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- ItalyAIRCORTITALCHIMICI S.P.A.
- BelgiumBudesonid Sandoz 0.5 mg/mlSandoz
- United StatesBudesonideSandoz Inc
- SwedenBudesonid Zentiva 0,5 mg/ml Suspension för nebulisatorZentiva k.s.
- FinlandBudesonide StadaSTADA Arzneimittel AG
- IrelandBudesonide Azure 1 mg/2 ml Nebuliser SuspensionAzure Pharmaceuticals Ltd.
- NetherlandsBudesonide 1000 microgram/2ml, Focus Care, vernevelsuspensieFocus Care Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Belgium · Budenofalk, Budesonid Sandoz
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Germany · Aquacort, Budapp Nasal
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Poland · Bds N, Benodil
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/422b1049-ab3f-4f1f-a65b-1363e60e64d8 GET /v1/drugs/422b1049-ab3f-4f1f-a65b-1363e60e64d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65554855",
"date_amm": "2003-08-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BUDÉSONIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension pour inhalation par nébuliseur",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about budésonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.